THE CHANGING FACE OF THERAPY FOR RHEUMATOID ARTHRITIS
- 1 August 1995
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 21 (3) , 845-852
- https://doi.org/10.1016/s0889-857x(21)00471-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Every‐other‐week methotrexate in patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- The efficacy and toxicity of combination therapy in rheumatoid arthritis. a meta‐analysisArthritis & Rheumatism, 1994
- Antirheumatic drugs: A proposed new classificationArthritis & Rheumatism, 1993
- A long‐term prospective study of the use of methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1988
- Long‐term prospective trial of low‐dose methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1988
- The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritisArthritis & Rheumatism, 1986
- Azathioprine in Rheumatoid Arthritis A Double‐Blind, Cross‐Over StudyArthritis & Rheumatism, 1973
- CONTROLLED TRIAL OF D(-)PENICILLAMINE IN SEVERE RHEUMATOID ARTHRITISThe Lancet, 1973
- AMODIAQUINE AND HYDROXYCHLOROQUINE IN RHEUMATOID ARTHRITISThe Lancet, 1959
- Salazopyrin, a new sulfanilamide preparation. A. Therapeutic Results in Rheumatic Polyarthritis. B. Therapeutic Results in Ulcerative Colitis. C. Toxic Manifestations in Treatment with Sulfanilamide Preparations.Acta Medica Scandinavica, 1942